The IRF5 rs2004640 (G/T) polymorphism is not a genetic risk factor for systemic lupus erythematosus in population from south India
Background & objectives: Genetic aberrations disrupting toll-like receptor and interferon homeostasis enhance the risk of systemic lupus erythematosus (SLE). Raised serum interferon-alpha (IFN-α) levels in SLE patients have been ascribed to polymorphism (rs2004640 G/T) in interferon regulatory f...
Main Authors: | Panneer Devaraju, Sonal Mehra, Reena Gulati, Paul T Antony, Vikramraj K Jain, Durga Prasanna Misra, Vir Singh Negi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2018-01-01
|
Series: | Indian Journal of Medical Research |
Subjects: | |
Online Access: | http://www.ijmr.org.in/article.asp?issn=0971-5916;year=2018;volume=147;issue=6;spage=560;epage=566;aulast= |
Similar Items
-
Interferon targeted therapies in systemic lupus erythematosus
by: Durga Prasanna Misra, et al.
Published: (2017-01-01) -
The protein tyrosine phosphatase, nonreceptor type 22-1858C->T (rs2476601) polymorphism is not a genetic risk factor for systemic lupus erythematosus in Indian Tamils
by: Panneer Devaraju, et al.
Published: (2017-01-01) -
Interferon Regulatory Factor 7 (IRF7) in Systemic Lupus Erythematosus
by: Verba, Mark J.
Published: (2020) -
IRF4 and IRGs Delineate Clinically Relevant Gene Expression Signatures in Systemic Lupus Erythematosus and Rheumatoid Arthritis
by: Javier Rodríguez-Carrio, et al.
Published: (2019-01-01) -
Spotlight on anifrolumab and its potential for the treatment of moderate-to-severe systemic lupus erythematosus: evidence to date
by: Felten R, et al.
Published: (2019-05-01)